Mutations of the BRAF gene in human cancer H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg, J Teague, ... Nature 417 (6892), 949-954, 2002 | 12696 | 2002 |
The role of BRAF V600 mutation in melanoma PA Ascierto, JM Kirkwood, JJ Grob, E Simeone, AM Grimaldi, M Maio, ... Journal of translational medicine 10, 1-9, 2012 | 942 | 2012 |
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma M Colombino, M Capone, A Lissia, A Cossu, C Rubino, V De Giorgi, ... Journal of Clinical Oncology 30, 2522-2529, 2012 | 558 | 2012 |
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy AM Grimaldi, E Simeone, D Giannarelli, P Muto, S Falivene, V Borzillo, ... Oncoimmunology 3 (5), e28780, 2014 | 402 | 2014 |
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab M Capone, D Giannarelli, D Mallardo, G Madonna, L Festino, AM Grimaldi, ... Journal for immunotherapy of cancer 6, 1-7, 2018 | 363 | 2018 |
Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer C Jones, A Mackay, A Grigoriadis, A Cossu, JS Reis-Filho, L Fulford, ... Cancer research 64 (9), 3037-3045, 2004 | 327 | 2004 |
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma E Simeone, G Gentilcore, D Giannarelli, AM Grimaldi, C Caracò, ... Cancer immunology, immunotherapy 63, 675-683, 2014 | 274 | 2014 |
Main roads to melanoma G Palmieri, M Capone, ML Ascierto, G Gentilcore, DF Stroncek, M Casula, ... Journal of translational medicine 7, 1-17, 2009 | 251 | 2009 |
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer G Castello, S Scala, G Palmieri, SA Curley, F Izzo Clinical immunology 134 (3), 237-250, 2010 | 217 | 2010 |
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells M Pisano, G Pagnan, M Loi, ME Mura, MG Tilocca, G Palmieri, D Fabbri, ... Molecular cancer 6, 1-12, 2007 | 177 | 2007 |
NF-κB as potential target in the treatment of melanoma G Madonna, CD Ullman, G Gentilcore, G Palmieri, PA Ascierto Journal of translational medicine 10, 1-8, 2012 | 167 | 2012 |
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis A D'Angelo, L Garzia, A André, P Carotenuto, V Aglio, O Guardiola, ... Cancer cell 5 (2), 137-149, 2004 | 163 | 2004 |
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality M Novelli, A Cossu, D Oukrif, A Quaglia, S Lakhani, R Poulsom, P Sasieni, ... Proceedings of the National Academy of Sciences 100 (6), 3311-3314, 2003 | 159 | 2003 |
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis P Liu, M Ge, J Hu, X Li, L Che, K Sun, L Cheng, Y Huang, MG Pilo, ... Hepatology 66 (1), 167-181, 2017 | 155 | 2017 |
Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression G Palmieri, M Strazzullo, PA Ascierto, SMR Satriano, A Daponte, ... Journal of clinical oncology 17 (1), 304-304, 1999 | 126 | 1999 |
MC1R variants increased the risk of sporadic cutaneous melanoma in darker‐pigmented Caucasians: A pooled‐analysis from the M‐SKIP project E Pasquali, JC García‐Borrón, MC Fargnoli, S Gandini, P Maisonneuve, ... International journal of cancer 136 (3), 618-631, 2015 | 124 | 2015 |
Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer SS Fois, P Paliogiannis, A Zinellu, AG Fois, A Cossu, G Palmieri International journal of molecular sciences 22 (2), 612, 2021 | 119 | 2021 |
Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets G Palmieri, MN Ombra, M Colombino, M Casula, MC Sini, A Manca, ... Frontiers in oncology 5, 183, 2015 | 118 | 2015 |
Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions PA Ascierto, G Palmieri, E Celentano, R Parasole, C Caracò, A Daponte, ... British Journal of Dermatology 142 (5), 893-898, 2000 | 114 | 2000 |
Sequencing of ipilimumab plus nivolumab and encorafenib plus binimetinib for untreated BRAF-mutated metastatic melanoma (SECOMBIT): a randomized, three-arm, open-label phase II … PA Ascierto, M Mandalà, PF Ferrucci, M Guidoboni, P Rutkowski, ... Journal of Clinical Oncology 41 (2), 212-221, 2023 | 109 | 2023 |